In the last trading session, 1.66 million CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares changed hands as the company’s beta touched 0.43. With the company’s per share price at $0.37 changed hands at -$0.03 or -8.12% during last session, the market valuation stood at $2.84M. CERO’s last price was a discount, traded about -26543.24% off its 52-week high of $98.58. The share price had its 52-week low at $0.40, which suggests the last value was -8.11% down since then.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Instantly CERO was in red as seen at the end of in last trading. With action -21.64%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -93.87%, with the 5-day performance at -21.64% in the red. However, in the 30-day time frame, CERo Therapeutics Holdings Inc (NASDAQ:CERO) is -43.46% down.

CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s Major holders

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 685.0 shares estimated at $251.0 under it, the former controlled 0.01% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.00% of the shares, roughly 56.0 shares worth around $20.0.